Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Cited by (1,000)

Items 301–400 of 1,000

1. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
   Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang · 2021 · Biomedicine & Pharmacotherapy
2. COVID-19 Drug Development
   Seungtaek Kim · 2021 · Journal of Microbiology and Biotechnology
3. Clinical Trials of Repurposed Antivirals for SARS-CoV-2
   Miguel Ángel Martı́nez · 2020 · Antimicrobial Agents and Chemotherapy
4. Clinical and cardiac characteristics of COVID‐19 mortalities in a diverse New York City Cohort
   Mark P. Abrams, Elaine Y. Wan, Marc Waase, John Morrow, Jose M. Dizon, Hirad Yarmohammadi, Jeremy P. Berman, Geoffrey Allan Rubin, Alexander Kushnir, Timothy Joseph Poterucha et al. · 2020 · Journal of Cardiovascular Electrophysiology
5. An enlightening role for cytokine storm in coronavirus infection
   Zhongyi Zhao, Yinhao Wei, Chuanmin Tao · 2020 · Clinical Immunology
6. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm
   Eddie W. Fakhouri, Stephen J. Peterson, Janish Kothari, Ragin Alex, Joseph I. Shapiro, Nader G. Abraham · 2020 · Antioxidants
7. Remdesivir and Mortality in Patients With Coronavirus Disease 2019
   George A. Diaz, Alyssa B Christensen, Tobias Pusch, Delaney Goulet, Shu‐Ching Chang, Gary L. Grunkemeier, Paul A. McKelvey, Ari A. Robicsek, Tom French, Guilford Parsons et al. · 2021 · Clinical Infectious Diseases
8. A stance data set on polarized conversations on Twitter about the efficacy of hydroxychloroquine as a treatment for COVID-19
   Ece Çiǧdem Mutlu, Toktam A. Oghaz, Jasser Jasser, Ege Tütüncüler, Amirarsalan Rajabi, Aida Tayebi, Özlem Özmen Garibay, Ivan I. Garibay · 2020 · Data in Brief
9. Cancer therapy and treatments during COVID-19 era
   Shaw M. Akula, Stephen Lee Abrams, Linda S. Steelman, Saverio Candido, Massimo Libra, Kvin Lerpiriyapong, Lucio Cocco, Giulia Ramazzotti, Stefano Ratti, Matilde Y. Follo et al. · 2020 · Advances in Biological Regulation
10. Improving Clinical Trial Enrollment — In the Covid-19 Era and Beyond
    Crystal M. North, Michael Lawrence Dougan, Chana A. Sacks · 2020 · New England Journal of Medicine
11. A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children
    Andi L. Shane, Alice I. Sato, Carol M. Kao, Felice C. Adler‐Shohet, Surabhi B Vora, Jeffery James Auletta, Sharon Nachman, Vanessa Raabe, Kengo Inagaki, Ibukunoluwa C. Kalu et al. · 2020 · Journal of the Pediatric Infectious Diseases Society
12. External validation of a clinical risk score to predict hospital admission and in-hospital mortality in COVID-19 patients
    Alexandra Halalau, Zaid Imam, Patrick Karabon, Nikhil P. Mankuzhy, Aciel Shaheen, John Tu, Christopher F Carpenter · 2020 · Annals of Medicine
13. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients
    Vinay V Nair, Nicholas Jandovitz, Jamie S. Hirsch, Mersema T. Abate, Sanjaya Kumar Satapathy, Nitzan C. Roth, Santiago J. Miyara, Sara Guevara, Adam M. Kressel, Alec Xiang et al. · 2020 · American Journal of Transplantation
14. The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
    Shagufta, Irshad Ahmad · 2021 · European Journal of Medicinal Chemistry
15. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Stav Rakedzon, Ami Neuberger, Abraham Jacob Domb, Neta Petersiel, Eli Schwartz · 2021 · Journal of Travel Medicine
16. Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA
    Devin Incerti, Shemra Rizzo, Xiao Li, Lisa Lindsay, Vincent Yau, Daniel Keebler, Jenny Chia, Larry W. Tsai · 2021 · BMJ Open
17. Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
    Vincent Dubée, Pierre‐Marie Roy, Bruno Vielle, Elsa Parot‐Schinkel, Odile Blanchet, Astrid Darsonval, Caroline Lefeuvre, Chadi Abbara, Sophie Boucher, Edouard Devaud et al. · 2021 · Clinical Microbiology and Infection
18. Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
    Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi et al. · 2021 · Frontiers in Microbiology
19. Ethical Challenges in Clinical Research During the COVID-19 Pandemic
    Barbara E. Bierer, Sarah White, J.M. Barnes, Luke C. Gelinas · 2020 · Journal of Bioethical Inquiry
20. The Urgency of Care during the Covid-19 Pandemic — Learning as We Go
    Eric J. Rubin, David P. Harrington, Joseph W. Hogan, Constantine A. Gatsonis, Lindsey Robert Baden, Mary Beth Hamel · 2020 · New England Journal of Medicine
21. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
    Augusto Filippo Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Marialaura Bonaccio, Roberto Cauda, Alessandro Gialluisi, Giovanni Guaraldi, Lorenzo Menicanti et al. · 2020 · Vascular Pharmacology
22. The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis
    Amir Shamshirian, Amirhossein Hessami, Keyvan Heydari, Reza Alizadeh‐Navaei, Mohammad Ali Ebrahimzadeh, George Wai Cheong Yip, Roya Ghasemian, Meghdad Sedaghat, Hananeh Baradaran, Soheil Mohammadi Yazdii et al. · 2020 · Annals of the Academy of Medicine Singapore
23. COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?
    Feras Jirjees, Ali K. Saad, Zahraa AlHano, Taher Hatahet, Hala Jehad Al-Obaidi, Yahya H. Dallal Bashi · 2021 · Infectious Disease Reports
24. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
    Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, Diana M Fernandez, Divya Mirchandani, Nathen E. Bopp, Patricia V. Aguilar, Jun-Gyu Park, Paula Pino Tamayo, Jennifer A. Delgado et al. · 2021 · Biomedicine & Pharmacotherapy
25. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
    Adrián Vladimir Hernández, Yuani M. Roman, Vinay Pasupuleti, Joshuan J. Barboza, Charles Michael White · 2020 · Annals of Internal Medicine
26. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis
    Meng Wang, Ting Wu, Zhihong Zuo, Yaxian You, Xinyuan Yang, Liangyu Pan, Ying Hu, Xuan Luo, Liping Jiang, Zanxian Xia et al. · 2020 · BMJ Supportive & Palliative Care
27. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside
    Jie Yu, Peiwei Chai, Shengfang Ge, Xianqun Fan · 2020 · Frontiers in Cell and Developmental Biology
28. HRS/EHRA/APHRS/LAHRS/ACC/AHA Worldwide Practice Update for Telehealth and Arrhythmia Monitoring During and After a Pandemic
    Niraj Varma, Nassir F. Marrouche, Luis Aguinaga, Christine M. Albert, Elena Arbelo, Jong‐Il Choi, Mina K. Chung, Giulio Conte, Lilas Dagher, Laurence Mark Epstein et al. · 2020 · Journal of the American College of Cardiology
29. Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019
    Zhiyao Wei, Yong‐Jian Geng, Ji Huang, Hai‐Yan Qian · 2020 · European Journal of Heart Failure
30. Renal Manifestations of Covid-19: Physiology and Pathophysiology
    Zaher Armaly, Safa Kinaneh, Karl L. Skorecki · 2021 · Journal of Clinical Medicine
31. Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
    Lili Yu, Xiaoying Zhang, Sarah Ye, Hongkai Lian, Hui Wang, Jianping Ye · 2022 · The Journal of Clinical Endocrinology & Metabolism
32. Dexamethasone use and mortality in hospitalized patients with coronavirus disease 2019: A multicentre retrospective observational study
    Nicolas Hoertel, Marina Sánchez Rico, Raphaël Vernet, Nathanaël Beeker, Antoine Neuraz, Jesús María Alvarado, Christel Daniel, Nicolás Paris, Alexandre Gramfort, Guillaume Lemaitre et al. · 2021 · British Journal of Clinical Pharmacology
33. Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
    Nicolas Hoertel, Marina Sánchez Rico, Raphaël Vernet, Anne‐Sophie Jannot, Antoine Neuraz, Carlos Blanco, Cédric Lemogne, Guillaume Airagnes, Nicolás Paris, Christel Daniel et al. · 2021 · Clinical Drug Investigation
34. Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction
    Acharya Balkrishna, Swati Haldar, Hoshiyar Singh, Partha Roy, Anurag Varshney · 2021 · Journal of Inflammation Research
35. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
    Efstathios Kastritis, George D. Kitas, Dimitrios Vassilopoulos, Georgios Giannopoulos, Meletios Athanasios Dimopoulos, Petros Paul Sfikakis · 2020 · Rheumatology International
36. Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model
    Jianling Yang, Meng Wu, Xu Liu, Qi Liu, Zhengyang Guo, Xueting Yao, Yang Liu, Cheng Cui, Haiyan Li, Chunli Song et al. · 2020 · Frontiers in Pharmacology
37. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19
    Laura Puzniak, Lyn Finelli, Kalvin C. Yu, Karri A A Bauer, Pamela A. Moise, Carisa S. De Anda, Latha Vankeepuram, Aryana Sepassi, Vikas Gupta · 2021 · BMC Infectious Diseases
38. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19
    Xiaoqi Wang, Bin Xin, Weihong Tan, Zhijian Xu, Kenli Li, Fei Li, Wu Zhong, Shaoliang Peng · 2021 · Briefings in Bioinformatics
39. Neuromuscular Diseases Care in the Era of COVID-19
    Bertran Recasens, Bernat, Rubio, Miguel Angel · 2020 · Frontiers in Neurology
40. Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection
    Thiago Domingos Corrêa, Gustavo Faissol Janot de Matos, Bruno de Arruda Bravim, Ricardo Luiz Cordioli, A Garrido, Murillo Santucci César de Assunção, Carmen Sílvia Valente Barbas, Karina Tavares Timenetsky, Roseny dos Reis Rodrigues, Hélio Penna Guimarães et al. · 2020 · Einstein (São Paulo)
41. Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity
    Stephen L. Sturley, Tamayanthi Rajakumar, Natalie Hammond, Katsumi Higaki, Z. Márka, Szabolcs Márka, Andrew B. Munkacsi · 2020 · Journal of Lipid Research
42. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19
    Jonathan Dale Casey, Nicholas James Johnson, Matthew W. Semler, Sean P. Collins, Neil R. Aggarwal, Roy G. Brower, Steven Y. Chang, John C. Eppensteiner, Michael R. Filbin, Kevin W. Gibbs et al. · 2020 · Annals of the American Thoracic Society
43. SARS‐CoV‐2 virus infection: Targets and antiviral pharmacological strategies
    Daniel Melo de Oliveira Campos, Umberto Laino Fulco, Cláudio Bruno Silva de Oliveira, Jonas Ivan Nobre Oliveira · 2020 · Journal of Evidence-Based Medicine
44. Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro
    Melle Holwerda, Philip V’kovski, Manon Wider, Volker Thiel, Ronald Dijkman · 2020 · Microorganisms
45. Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19
    Jessica Myers Franklin, Kueiyu Joshua Lin, Nicolle M. Gatto, Jeremy A. Rassen, Robert J. Glynn, Sebastian Schneeweiß · 2021 · Clinical Pharmacology & Therapeutics
46. Association of hypertension and incident diabetes in Chinese adults: a retrospective cohort study using propensity-score matching
    Yang Wu, Haofei Hu, Jinlin Cai, Runtian Chen, Xin Zuo, Heng Wei Cheng, Dewen Yan · 2021 · BMC Endocrine Disorders
47. Lung histopathological findings in COVID-19 disease – a systematic review
    Giuseppe Pannone, Vito Carlo Alberto Caponio, Ilenia Sara De Stefano, Maria Antonietta Ramunno, Mario Meccariello, Alessio Agostinone, Maria Carmela Pedicillo, Giuseppe Troiano, Khrystyna Zhurakivska, Tommaso Cassano et al. · 2021 · Infectious Agents and Cancer
48. Role of phytoconstituents in the management of COVID-19
    Amiya Das, Deepti Pandita, Gaurav Kumar Jain, Pallavi Agarwal, Ajmer Singh Grewal, Roop Kishan Khar, Viney Lather · 2021 · Chemico-Biological Interactions
49. A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
    Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, Senthilkumar Natesan, Dewi Megawati, Karam Pal Singh, Izabela Michalak, Kuldeep Dhama · 2022 · Narra J
50. Covid‐19 pandemic and pregnancy
    Satoshi Hayakawa, Shihoko Komine‐Aizawa, Gil Mor · 2020 · Journal of obstetrics and gynaecology research
51. SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
    Simona Alexandra Iacob, Diana Gabriela Iacob · 2020 · Frontiers in Pharmacology
52. Preparedness and Reorganization of Care for Coronavirus Disease 2019 Patients in a Swiss ICU: Characteristics and Outcomes of 129 Patients
    Steve Primmaz, Christophe Le Terrier, Noémie Suh, François Ventura, Filippo Boroli, Karim Bendjelid, Sara Cereghetti, Raphaël Giraud, Claudia Paula Heidegger, Déborah Pugin et al. · 2020 · Critical Care Explorations
53. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
    Arif Jamal Siddiqui, Sadaf Jahan, Syed Amir Ashraf, Mousa M. Alreshidi, Mohammad Saquib Ashraf, Mitesh B. Patel, Mejdi Snoussi, Ritu Singh, Mohd Adnan · 2020 · Journal of Biomolecular Structure and Dynamics
54. Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
    Chris A. Gentry, Mary Beth Humphrey, Sharanjeet K. Thind, Sage C. Hendrickson, George Kurdgelashvili, Riley J. Williams · 2020 · The Lancet Rheumatology
55. The “sex gap” in COVID-19 trials: a scoping review
    Veronique M. M. M. Schiffer, Emma B N J Janssen, Bas C. T. van Bussel, Laura M Jorissen, Jeanette Tas, Jan-Willem E. M. Sels, Dennis C. J. J. Bergmans, Trang Dinh, Sander M. J. van Kuijk, Anisa Hana et al. · 2020 · EClinicalMedicine
56. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
    Donovan Anthony McGrowder, Fabian G. Miller, Melisa Anderson Cross, Lennox Anderson-Jackson, Sophia Bryan, Lowell Dilworth · 2021 · Diseases
57. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
    Sean Pinney, Gennaro Giustino, Jonathan L. Halperin, Jeffrey Ian Mechanick, Eric Neibart, Jeffrey W. Olin, Robert S. Rosenson, Valentı́n Fuster · 2020 · Journal of the American College of Cardiology
58. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
    Fiona Limanaqi, Carla Letizia Busceti, Francesca Biagioni, Gloria Lazzeri, Maurizio Forte, Sonia Schiavon, Sebastiano Sciarretta, Giacomo Frati, Francesco Fornai · 2020 · Antioxidants
59. Hydroxychloroquine in COVID-19 Patients: Pros and Cons
    Nour K. Younis, Rana O. Zareef, Sally Al Hassan, Fadi Fouad Bitar, Ali Hussein Eid, Mariam Toufic Arabi · 2020 · Frontiers in Pharmacology
60. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial
    Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, Zuohan Xiao, Wei-Jun Du, Jing Yao, Guojun Li et al. · 2021 · International Immunopharmacology
61. Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
    Douglas A. Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav G. Patel, Tomi Wei Jun, Thomas A. Jandl et al. · 2020 · Cancer Medicine
62. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae
    Brandon Hamm, Lisa J. Rosenthal · 2020 · Psychosomatics
63. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection
    Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio, Andrea Fabbri · 2020 · Expert Review of Anti-infective Therapy
64. Generation of Chicken IgY against SARS‐COV‐2 Spike Protein and Epitope Mapping
    Yan Lü, Yajun Wang, Zhen Zhang, Jingliang Huang, Yao Meicun, Guobin Huang, Yuanyuan Ge, Peichun Zhang, Huaxin Huang, Yong Wang et al. · 2020 · Journal of Immunology Research
65. Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies
    Christel Renoux, Laurent Azoulay, Samy Suissa · 2021 · American Journal of Epidemiology
66. Combating COVID-19: Lessons learnt particularly among developing countries and the implications
    Brian Godman · 2020 · Bangladesh Journal of Medical Science
67. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
    Matthieu Roustit, Romain Guilhaumou, Mathiéu Molimard, Milou‐Daniel Drici, Silvy Laporte, Jean‐Louis Montastruc · 2020 · Therapies
68. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
    JingKang Sun, YuTing Chen, Xiude Fan, Xiaoyun Wang, Qunying Han, Zhengwen Liu · 2020 · Postgraduate Medicine
69. Remdesivir: A beacon of hope from Ebola virus disease to COVID ‐19
    Ali Nili, Abolfazl Farbod, Afarin Neishabouri, Mohammad Mozafarihashjin, Soheil Tavakolpour, Hamidreza Mahmoudi · 2020 · Reviews in Medical Virology
70. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus
    Kirk U. Knowlton · 2020 · Journal of Molecular and Cellular Cardiology
71. Potential diagnostics and therapeutic approaches in COVID-19
    Pratibha Kumari, Archana Kumari Singh, Moses Rinchui Ngasainao, Ilma Shakeel, Sanjay Kumar, Seema Lal, Anchal Singhal, Sukhwinder Singh Sohal, Indrakant Kumar Singh, Md. Imtaiyaz Hassan · 2020 · Clinica Chimica Acta
72. Primed for global coronavirus pandemic: Emerging research and clinical outcome
    Shakir Ahamad, Scotty Branch, Shea Harrelson, Mohd Kamil Hussain, Mohammad Saquib, Saeed Khan · 2020 · European Journal of Medicinal Chemistry
73. Identifying public concerns and reactions during the COVID‐19 pandemic on Twitter: A text‐mining analysis
    Zainab Toteh Osakwe, Izuagie Attairu Ikhapoh, Bhavleen Kaur Arora, Omonigho M. Bubu · 2020 · Public Health Nursing
74. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
    Rajnish Kumar, Anju Sharma, Janmejai Kumar Srivastava, Mohammed Haris Siddiqui, Md. Sahab Uddin, Lotfi Aleya · 2021 · Environmental Science and Pollution Research
75. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery
    Yao Chen, Meixiu Li, Guo‐Dong Lu, Han‐Ming Shen, Jing Zhou · 2021 · International Journal of Biological Sciences
76. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
    Serena Colafrancesco, Rossana Scrivo, Cristiana Barbati, Fabrizio Conti, Roberta Priori · 2020 · Frontiers in Immunology
77. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients
    Adriana J. J. Lammers, Richard M. Brohet, R.E.P. Theunissen, Corinna Köster, R. Rood, Dominique W. M. Verhagen, Kees Brinkman, R.J. Hassing, A. Dofferhoff, Rachida el Moussaoui et al. · 2020 · International Journal of Infectious Diseases
78. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
    Ilad Alavi Darazam, Shervin Shokouhi, Masoud Mardani, Mohamad Amin Pourhoseingholi, Mohammad Mahdi Rabiei, Firouze Hatami, Minoosh Shabani, Omid Moradi, Farid Javandoust Gharehbagh, Seyed Sina Naghibi Irvani et al. · 2021 · International Immunopharmacology
79. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection
    Melanie R. Nicol, Abhay Joshi, Matthew L. Rizk, Philip E. Sabato, Radojka M. Savić, DAVID L. WESCHE, Jenny Zheng, Jack Cook · 2020 · Clinical Pharmacology & Therapeutics
80. The Course of Mild and Moderate COVID-19 Infections—The Unexpected Long-Lasting Challenge
    Lu Xia, Jun Chen, Thomas Friedemann, Zongguo Yang, Yun Ling, Xuhui Liu, Shuihua Lu, Tao Li, Zhigang Song, Wei Huang et al. · 2020 · Open Forum Infectious Diseases
81. Obesity and the Risk of Intubation or Death in Patients With Coronavirus Disease 2019
    Rachel C. Frank, Sean R Mendez, Elizabeth K. Stevenson, James Sawalla Guseh, Mabel Chung, Michael G. Silverman · 2020 · Critical Care Medicine
82. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
    Jinghong Li, Qi Wei, Willis X. Li, Karen Clare McCowen, Wei Xiong, Jiao Liu, Wenlijun Jiang, Traci Marin, Robert L. Thomas, Ming He et al. · 2020 · Endocrine Practice
83. Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2
    Shuai Ge, Xiangjun Wang, Yajing Hou, Yuexin Lv, Cheng Wang, Huaizhen He · 2021 · European Journal of Pharmacology
84. MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2
    Lucia Natarelli, Luca Parca, Fabio Virgili, Tommaso Mazza, Christian Weber, Deborah Fratantonio · 2021 · Non-Coding RNA
85. Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins
    Chinmayi Joshi, Armi M Chaudhari, Chaitanya G. Joshi, Madhvi N. Joshi, Snehal B. Bagatharia · 2021 · Journal of Biomolecular Structure and Dynamics
86. Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
    Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori et al. · 2021 · Infectious Diseases and Therapy
87. Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients
    Fabiola Olivieri, Jacopo Sabbatinelli, Anna Rita Bonfigli, Riccardo Sarzani, Piero Giordano, Antonio Cherubini, Roberto Antonicelli, Yuri Rosati, Simona Del Prete, Mirko Di Rosa et al. · 2022 · Mechanisms of Ageing and Development
88. COVID-19: the new challenge for rheumatologists. First update
    Francesco Ferro, Elena Elefante, Ilaria Puxeddu, Chiara Baldini, Elena Bartoloni, Claudia Baratè, Sara Galimberti, Rosaria Talarico, Marta Mosca, Stefano Bombardieri · 2020 · Clinical and Experimental Rheumatology
89. Public Perceptions of Resuming Elective Surgery During the COVID-19 Pandemic
    Michael A. Moverman, Richard N. Puzzitiello, Nicholas R. Pagani, Charles Lowry Barnes, Andrew Jawa, Mariano E. Menendez · 2020 · The Journal of Arthroplasty
90. Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
    Filippo Albani, Federica Fusina, Alessia Giovannini, Pierluigi Ferretti, Anna Granato, Chiara Prezioso, Danilo Divizia, Alessandra Sabaini, Marco Marri, Elena Malpetti et al. · 2020 · Journal of Clinical Medicine
91. Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review
    Chadwick C. Prodromos, Tobias Rumschlag · 2020 · New Microbes and New Infections
92. Recent progress of antiviral therapy for coronavirus disease 2019
    Mengmeng Zhao, Jishou Zhang, Hanli Li, Zhen Luo, Jing Ye, Yao Qun Xu, Zhen Wang, Di Ye, Jianfang Liu, Dan Li et al. · 2020 · European Journal of Pharmacology
93. Repurposing Anti-Cancer Drugs for COVID-19 Treatment
    Nicholas C. Borcherding, Yogesh S. Jethava, Praveen Vikas · 2020 · Drug Design Development and Therapy
94. Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital
    Anahita Mostaghim, Pranay Sinha, Catherine G. Bielick, Selby Knudsen, Indeevar R. Beeram, Laura Forsberg White, Caroline Margaret Apovian, Manish Sagar, Natasha S. Hochberg · 2020 · PLoS ONE
95. COVID-19: Update on Its Ocular Involvements, and Complications From Its Treatments and Vaccinations
    Timothy P.H. Lin, Chung-Nga Ko, Ke Zheng, Kenny H.W. Lai, Raymond L.M. Wong, Allie Lee, Shaochong Zhang, Suber S. Huang, Kelvin H. Wan, Dennis S.C. Lam · 2021 · Asia-Pacific Journal of Ophthalmology
96. A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
    Dawid Maciorowski, Samir El Idrissi, Yash A. Gupta, Brian Medernach, Michael B. Burns, Daniel P. Becker, Ravi V. Durvasula, Prakasha Kempaiah · 2020 · SLAS DISCOVERY
97. Viral modulation of lipid rafts and their potential as putative antiviral targets
    Yee Jing Gee, Yi Lin Sea, Sunil Kumar Lal · 2022 · Reviews in Medical Virology
98. Chronic treatment with hydroxychloroquine and SARS‐CoV‐2 infection
    António Ferreira, António Oliveira‐e‐Silva, Paulo Bettencourt · 2020 · Journal of Medical Virology
99. COVID-19 therapy: What weapons do we bring into battle?
    Sinara Mônica Vitalino de Almeida, José Cleberson Santos Soares, Keriolaine Lima dos Santos, Josival Emanuel Ferreira Alves, Amélia Galdino Ribeiro, Íris Trindade Tenório Jacob, Cindy Juliane da Silva Ferreira, Jéssica Celerino dos Santos, Jamerson Ferreira de Oliveira, Luiz Bezerra de Carvalho et al. · 2020 · Bioorganic & Medicinal Chemistry
100. Territories Under Siege: Risks of the Decimation of Indigenous and Quilombolas Peoples in the Context of COVID-19 in South Brazil
     Maurício Polidoro, Francisco Mendonça, Stela Nazareth Meneghel, Alan Alves-Brito, Marcelo Rodrigues Gonçalves, Fernanda Souza de Bairros, Daniel Canavese · 2020 · Journal of Racial and Ethnic Health Disparities